Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma

被引:59
作者
Ekici, A [1 ]
Ekici, M [1 ]
Erdemoglu, AK [1 ]
机构
[1] Kriikkale Univ, Fac Med, Dept Chest Dis, TR-07100 Kirikkale, Turkey
关键词
bronchial asthma; bronchial hyperresponsiveness; azithromycin; macrolides; histamine;
D O I
10.1081/JAS-120002199
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The effect of azithromycin on bronchial hyperresponsiveness was measured in a group of 11 patients with mild asthma. Azithromycin 250 mg orally was administered intermittently to all the patients twice a week for eight weeks. The only other treatment was inhaled beta2 agonist, when required. A histamine inhalation test was performed at the beginning and at the fourth and the eighth week of the study. The mean PC20 values increased significantly over the initial value at the eighth week after the administration of azithromycin (p < 0.05) but mean values for FEV1 and FEV1 percent predicted did not differ significantly. These results suggested that eight weeks of intermittent, low-dose administration of azithromycin in patients with mild asthma might reduce the severity of bronchial hyperresponsiveness.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 20 条
  • [1] Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5
    Adachi, T
    Motojima, S
    Hirata, A
    Fukuda, T
    Kihara, N
    Kosaku, A
    Ohtake, H
    Makino, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) : S207 - S215
  • [2] Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils
    Anderson, R
    Theron, AJ
    Feldman, C
    [J]. INFLAMMATION, 1996, 20 (06) : 693 - 705
  • [3] BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY
    COCKCROFT, DW
    KILLIAN, DN
    MELLON, JJA
    HARGREAVE, FE
    [J]. CLINICAL ALLERGY, 1977, 7 (03): : 235 - 243
  • [4] Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro
    Feldman, C
    Anderson, R
    Theron, AJ
    Ramafi, G
    Cole, PJ
    Wilson, R
    [J]. INFLAMMATION, 1997, 21 (06) : 655 - 665
  • [5] Hirohata S, 1995, Arerugi, V44, P1322
  • [6] EFFICACY AND SAFETY OF LOW-DOSE TROLEANDOMYCIN THERAPY IN CHILDREN WITH SEVERE, STEROID-REQUIRING ASTHMA
    KAMADA, AK
    HILL, MR
    IKLE, DN
    BRENNER, AM
    SZEFLER, SJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (04) : 873 - 882
  • [7] FK-506, A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM A STREPTOMYCES .2. IMMUNOSUPPRESSIVE EFFECT OF FK-506 INVITRO
    KINO, T
    HATANAKA, H
    MIYATA, S
    INAMURA, N
    NISHIYAMA, M
    YAJIMA, T
    GOTO, T
    OKUHARA, M
    KOHSAKA, M
    AOKI, H
    OCHIAI, T
    [J]. JOURNAL OF ANTIBIOTICS, 1987, 40 (09) : 1256 - 1265
  • [8] Kobayashi H, 1995, Kansenshogaku Zasshi, V69, P711
  • [9] ANTIASTHMATIC ACTIVITY OF A MACROLIDE ANTIBIOTIC, ROXITHROMYCIN - ANALYSIS OF POSSIBLE MECHANISMS IN-VITRO AND IN-VIVO
    KONNO, S
    ASANO, K
    KUROKAWA, M
    IKEDA, K
    OKAMOTO, K
    ADACHI, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 105 (03) : 308 - 316
  • [10] ANTIALLERGIC ACTIVITY OF ROXITHROMYCIN - INHIBITION OF INTERLEUKIN-5 PRODUCTION FROM MOUSE LYMPHOCYTE-T
    KONNO, S
    ADACHI, M
    ASANO, K
    OKAMOTO, K
    TAKAHASHI, T
    [J]. LIFE SCIENCES, 1993, 52 (04) : PL25 - PL30